Obstructive Sleep Apnea

More patients without continuous airway positive pressure coverage in their region said that cost affected their choice of treatment than patients with CPAP coverage, according to results published in Annals of the American Thoracic Society.

The FDA approved an obstructive sleep apnea neurostimulation therapy for patients aged 13 years and older with Down syndrome, according to a manufacturer-issued press release.

Excessive daytime sleepiness is a common symptom of several sleep disorders, including obstructive sleep apnea, which is estimated to affect 10% to 30% of adults in the U.S and often goes underdiagnosed, according to the Sleep Foundation.

Patients with obstructive sleep apnea showed impaired emotional memory after one night of sleep, according to study results published in Annals of the American Thoracic Society.

Adults with obstructive sleep apnea faced elevated risks for developing COVID-19 and experiencing COVID-19-related complications, according to study results published in Thorax.

Adults with obstructive sleep apnea demonstrated low predicted bone mineral density, which could impact the strength of their bones and teeth, according to study results published in Cranio.

The FDA has granted 510(k) clearance to an at-home test device that can diagnose obstructive sleep apnea and other sleep-related breathing disorders, according to a press release.

A higher BMI did not appear to increase risk for sarcoidosis, according to study results published in CHEST.

Indira Gurubhagavatula, MD, MPH, associate professor of medicine and director of the Sleep Medicine Fellowship at Penn Medicine, spoke with Healio about the relationship between COVID-19 and sleep.

Intermediate or high risk for obstructive sleep apnea was associated with a 50% greater chance of having glaucoma in a population of Singaporean adults, with researchers reporting a twofold greater risk for glaucoma in Malay individuals.